Current and future therapeutic approaches for osteosarcoma | 2017/12/14 | English | 464 |
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies | 2011/02/01 | English | 299 |
Chemotherapy resistance in osteosarcoma: current challenges and future directions | 2006/07/01 | English | 271 |
Overview and recent advances in the treatment of neuroblastoma | 2017/03/15 | English | 246 |
The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care | 2018/07/18 | English | 242 |
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor | 2007/04/01 | English | 235 |
Nonhistone protein acetylation as cancer therapy targets | 2010/06/01 | English | 210 |
A new understanding in the epidemiology of melanoma | 2010/11/01 | English | 207 |
Inflammation in the development of lung cancer: epidemiological evidence | 2008/04/01 | English | 205 |
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors | 2010/07/01 | English | 192 |
Metastatic osteosarcoma: a challenging multidisciplinary treatment | 2016/04/06 | English | 186 |
Head and neck cancer: past, present and future | 2006/07/01 | English | 172 |
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy | 2009/03/01 | English | 169 |
A comprehensive review of protein kinase inhibitors for cancer therapy | 2018/10/09 | English | 151 |
The role of platelet activation in tumor metastasis | 2008/08/01 | English | 139 |
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer | 2017/11/26 | English | 135 |
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases | 2010/05/01 | English | 133 |
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles | 2016/04/08 | English | 129 |
Nanotechnology for targeted cancer therapy | 2007/06/01 | English | 126 |
Oncolytic viruses: a novel form of immunotherapy | 2008/10/01 | English | 124 |
Current systemic therapy for metastatic melanoma | 2009/05/01 | English | 120 |
Stathmin 1: a novel therapeutic target for anticancer activity | 2008/09/01 | English | 119 |
Development of histone deacetylase inhibitors for cancer treatment | 2007/04/01 | English | 118 |
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade | 2012/12/01 | English | 117 |
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy | 2010/11/01 | English | 115 |
Anti-GD2 immunotherapy for neuroblastoma | 2017/08/14 | English | 114 |
Autophagy and endocrine resistance in breast cancer | 2011/08/01 | English | 112 |
The role of Gliadel wafers in the treatment of high-grade gliomas | 2013/12/01 | English | 111 |
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review | 2017/08/03 | English | 108 |
Screening of colorectal cancer: present and future | 2017/10/26 | English | 107 |